Bruce E Sands Selected Research

Steroids

1/2022	Prospective Cohort Study to Investigate the Safety of Preoperative Tumor Necrosis Factor Inhibitor Exposure in Patients With Inflammatory Bowel Disease Undergoing Intra-abdominal Surgery.
1/2020	Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease.
10/2018	Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative Colitis.
2/2015	Body image dissatisfaction in patients with inflammatory bowel disease.
8/2012	Basiliximab does not increase efficacy of corticosteroids in patients with steroid-refractory ulcerative colitis.
10/2010	Are gastroenterologists less tolerant of treatment risks than patients? Benefit-risk preferences in Crohn's disease management.
10/2008	Perioperative treatment with infliximab in patients with Crohn's disease and ulcerative colitis is not associated with an increased rate of postoperative complications.
9/2007	Crohn's disease patients' risk-benefit preferences: serious adverse event risks versus treatment efficacy.
12/2003	Risk of early surgery for Crohn's disease: implications for early treatment strategies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bruce E Sands Research Topics

Disease

98	Ulcerative Colitis 05/2024 - 09/2004
80	Crohn Disease (Crohn's Disease) 02/2024 - 11/2003
39	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2024 - 07/2006
28	Infections 12/2023 - 09/2004
18	Inflammation (Inflammations) 03/2024 - 11/2005
12	Neoplasms (Cancer) 02/2024 - 10/2009
12	Necrosis 01/2023 - 01/2011
7	Hemorrhage 12/2023 - 12/2005
7	Skin Neoplasms (Skin Cancer) 04/2023 - 01/2017
6	Herpes Zoster 06/2023 - 01/2017
6	Body Weight (Weight, Body) 01/2019 - 02/2004
5	Colitis 01/2023 - 12/2008
5	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 08/2010
5	Lymphoma (Lymphomas) 10/2010 - 08/2006
4	Sepsis (Septicemia) 01/2024 - 08/2006
4	Ulcer 10/2023 - 04/2012
4	Opportunistic Infections (Opportunistic Infection) 06/2023 - 10/2010
4	Rheumatoid Arthritis 01/2021 - 08/2010
4	Fistula 09/2007 - 02/2004
3	Tuberculosis (Tuberculoses) 12/2023 - 10/2009
3	Nasopharyngitis 12/2023 - 08/2013
3	Pathologic Constriction (Stenosis) 10/2023 - 08/2015
3	Melanoma (Melanoma, Malignant) 04/2023 - 01/2019
3	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 10/2015 - 05/2003
3	Progressive Multifocal Leukoencephalopathy 01/2014 - 09/2007
2	Proctitis 04/2024 - 11/2022
2	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 06/2023
2	Arthralgia (Joint Pain) 06/2023 - 01/2011
2	Venous Thrombosis (Deep-Vein Thrombosis) 04/2023 - 11/2019
2	Pulmonary Embolism 04/2023 - 11/2019
2	Dysbiosis 01/2023 - 05/2015
2	Malnutrition (Nutritional Deficiencies) 01/2023 - 12/2022
2	Colonic Neoplasms (Colon Cancer) 01/2023 - 10/2010
2	Headache (Headaches) 11/2022 - 08/2013
2	Basal Cell Carcinoma (Rodent Ulcer) 08/2022 - 10/2012
2	Psoriatic Arthritis 01/2022 - 01/2021
2	Disease Progression 01/2021 - 01/2021
2	Diarrhea 01/2016 - 05/2003
2	Abdominal Pain (Pain, Abdominal) 08/2013 - 12/2003
2	Abscess 09/2007 - 10/2006
1	Pneumonia (Pneumonitis) 01/2024

Drug/Important Bio-Agent (IBA)

31	vedolizumabIBA 01/2024 - 08/2013
20	tofacitinibIBA 01/2024 - 01/2017
19	Ustekinumab (CNTO 1275)FDA Link 02/2024 - 10/2012
19	Infliximab (Remicade)FDA Link 01/2018 - 02/2004
15	Monoclonal AntibodiesIBA 03/2024 - 02/2004
14	Interleukin-23 (Interleukin 23)IBA 03/2024 - 07/2010
14	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2024 - 10/2006
14	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2009
11	Janus Kinase InhibitorsIBA 07/2023 - 01/2017
11	Tumor Necrosis Factor InhibitorsIBA 01/2022 - 10/2012
10	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2024 - 01/2004
9	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2023 - 12/2012
9	Immunologic Factors (Immunomodulators)IBA 01/2023 - 12/2008
9	SteroidsIBA 01/2022 - 12/2003
8	IntegrinsIBA 01/2023 - 08/2013
7	mirikizumabIBA 03/2024 - 01/2022
7	Interleukin-12 (IL 12)IBA 01/2023 - 07/2010
7	C-Reactive ProteinIBA 12/2022 - 10/2015
5	guselkumabIBA 03/2024 - 01/2022
5	Adalimumab (Humira)FDA Link 09/2023 - 01/2019
5	CytokinesIBA 01/2023 - 08/2007
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2015
3	ozanimodIBA 05/2024 - 01/2017
3	etrasimodIBA 04/2024 - 06/2021
3	Immunosuppressive Agents (Immunosuppressants)IBA 12/2023 - 01/2019
3	Methotrexate (Mexate)FDA LinkGeneric 09/2023 - 08/2010
3	Sphingosine-1-Phosphate ReceptorsIBA 07/2023 - 01/2017
3	Janus KinasesIBA 04/2023 - 01/2018
3	InterleukinsIBA 01/2023 - 12/2012
3	LipidsIBA 01/2021 - 01/2017
3	acceleratory factor from growth hormone (AcG)IBA 07/2018 - 01/2013
3	Natalizumab (Tysabri)FDA Link 01/2017 - 01/2007
2	golimumab FDA Link 03/2024 - 01/2023
2	W 12IBA 03/2024 - 10/2023
2	omega-Chloroacetophenone (Mace)IBA 02/2024 - 04/2023
2	Prostaglandins AIBA 01/2024 - 01/2022
2	MEDI2070IBA 12/2023 - 07/2017
2	Phenobarbital (Luminal)FDA Link 10/2023 - 04/2012
2	Hormones (Hormone)IBA 01/2023 - 11/2003
2	MicronutrientsIBA 01/2023 - 12/2022
2	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 08/2022 - 10/2008
2	InterferonsIBA 12/2021 - 07/2017
2	Immunoglobulin A (IgA)IBA 01/2021 - 05/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 01/2016
2	GED0301IBA 01/2020 - 01/2018
2	AlbuminsIBA 08/2017 - 01/2015
2	eldelumabIBA 07/2017 - 04/2016
2	salicylhydroxamic acid (SHAM)IBA 09/2013 - 08/2008
2	LigandsIBA 12/2012 - 03/2008
2	Azathioprine (Imuran)FDA LinkGeneric 01/2012 - 10/2008
2	Sodium Glutamate (Accent)IBA 04/2005 - 10/2004
2	alosetron (Lotronex)FDA Link 03/2004 - 05/2003
1	SphingosineIBA 04/2024

Therapy/Procedure

75	Therapeutics 05/2024 - 12/2003
9	Colectomy 01/2024 - 08/2007
5	Biological Therapy 02/2022 - 01/2012
4	Blood Component Removal (Apheresis) 09/2013 - 07/2006
2	Wearable Electronic Devices 01/2024 - 01/2021
2	Appendectomy 11/2008 - 10/2007